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Background: This study aimed to document malaria case management practices in Papua New Guinea prior to the
introduction of a revised national malaria treatment protocol. The revised protocol stipulates routine testing of
malaria infection by rapid diagnostic test or microscopy, anti-malarial prescription to test positive cases only, and
the introduction of a new artemisinin-based first-line anti-malarial. Findings presented in this paper primarily focus
on diagnostic, prescription and treatment counselling practices.
Methods: In a national cross-sectional survey of 79 randomly selected health facilities, data were collected via non-
participant observation of the clinical case management of patients presenting with fever or a recent history of
fever. Data were recorded on a structured clinical observation instrument.
Results: Overall, 15% of observed fever patients (n = 468) were tested for malaria infection by rapid diagnostic test
and a further 3.6% were tested via microscopy. An anti-malarial prescription was made in 96.4% (451/468) of cases,
including 100% (17/17) of test positive cases and 82% (41/50) of test negative cases. In all, 79.8% of anti-malarial
prescriptions conformed to the treatment protocol current at the time of data collection. The purpose of the
prescribed medication was explained to patients in 63.4% of cases, dosage/regimen instructions were provided in
75.7% of cases and the possibility of adverse effects and what they might look like were discussed in only 1.1% of
cases.
Conclusion: The revised national malaria treatment protocol will require a substantial change in current clinical
practice if it is to be correctly implemented and adhered to. Areas that will require the most change include the
shift from presumptive to RDT/microscopy confirmed diagnosis, prescribing (or rather non-prescribing) of anti-
malarials to patients who test negative for malaria infection, and the provision of thorough treatment counselling. A
comprehensive clinician support programme, possibly inclusive of ‘booster’ training opportunities and regular
clinical supervision will be needed to support the change.Background
Malaria is a major public health problem in Papua New
Guinea (PNG). In 2009, out of a population of close to
seven million people, official statistics report 1,431,395
suspected malaria cases, 22,896 inpatient malaria cases
and 604 malaria attributable deaths [1]. Malaria endem-
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reproduction in any medium, provided the orcoastal and island regions to unstable transmission with
localized epidemics at altitudes between 1,300 to 1,600
m to no transmission above 1,700 m [2]. In total, over
90% of the population are considered at risk of malaria
infection and over 50% live in areas with potentially high
transmission below 1,200 m [1,2]. Anti-malarial medi-
cines are available via the retail sector in PNG and trad-
itional therapy continues to be utilized [3], although
evidence suggests that malaria treatment is most often
sought from government and mission-run health facil-
ities [4,5]. This health facility network comprises four
levels of service provision including hospital, health
centre, health sub-centre, and aid-post. The hospital isLtd This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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the number and range of clinical staff employed and the
number and range of clinical services provided. The aid-
post is the smallest unit of health service provision and
is typically staffed by a single health worker with two
years clinical training. In theory, all cases of uncompli-
cated malaria are treatable at the aid-post level with se-
vere cases referred to a health centre or hospital.
Malaria case management across this health facility net-
work is standardized against a national treatment protocol.
The protocol current at the time of this study (from here
on referred to as the ‘former’ protocol) stipulated the
provision of anti-malarials to all children with fever and,
where microscopy is not available, presumptive diagnosis
in febrile adults [6,7]. First line treatments included: amo-
diaquine plus sulphadoxine-pyrimethamine (SP) or
chloroquine plus SP for the treatment of uncomplicated
malaria and artemether injection plus artesunate tablets
plus SP or, if artemether and artesunate we are unavail-
able, quinine injection plus quinine tablets plus SP, for the
treatment of severe malaria. Given widespread resistance
to these first line anti-malarials in PNG [8-10], and in line
with international recommendations [11], a revised na-
tional malaria treatment protocol was introduced in late
2011. The revised protocol stipulates that all fever or sus-
pected malaria cases be tested for malaria infection by mi-
croscopy or rapid diagnostic test (RDT) with the possible
exception of children under five years of age with signs of
severe illness, introduces artemether-lumefantrine (AL) as
the new first-line treatment for uncomplicated falciparum
malaria, AL plus primaquine as the new first-line treat-
ment for uncomplicated vivax malaria and artesunate in-
jection plus AL for the first-line treatment of severe
malaria, whether falciparum or vivax [12]. These guide-
lines emphasize the importance of patient counselling par-
ticularly in order to ensure patient adherence to the
treatment regimen and to minimize the risk of develop-
ment of drug resistance. In addition, potential side effects
associated with primaquine in G6PD deficient individuals
may warrant close supervision of patients on primaquine
treatment.
The introduction of a test-and-treat policy is a major
change to the routine of health care workers who are
used to treating most malaria cases presumptively based
on a clinical diagnosis. The experience of other malari-
ous countries that have introduced similar revisions to
their respective malaria treatment protocols suggests
health worker adherence may be problematic. In Kenya,
for example, three years after the implementation of a
new treatment protocol stipulating routine microscopy
or RDT testing of all adult fever cases and the prescrip-
tion of AL to test positive cases, testing rates in health
facilities with RDT or microscopy available did not ex-
ceed 54% and nearly a third of test negative cases wereprescribed AL [13]. Similar or worse rates of health
worker adherence to malaria case management guide-
lines have been reported elsewhere [14-16]. Attempts to
understand why health workers may be reluctant to ad-
here to current best practice malaria case management
guidelines suggest a possible lack of confidence in RDT
results, intentional rationing of ACT prescription due to
fear of possible stock-outs or the perceived cost, a desire
to utilize (rather than waste) existing stocks of former
first-line anti-malarials, and inappropriate and/or inad-
equate training and follow-up support [17,18].
Whatever the barriers to a quick and full adherence to
a new treatment protocol, it is reasonable to assume that
the greater the change in clinical practice required, the
greater the potential obstacles are likely to be. At the
time of this study it was largely unknown how substan-
tial a shift in malaria case management practice the
revised guidelines would require of PNG health workers.
Malaria microscopy and RDT kits were available in PNG
prior to the new protocol, but the extent of their avail-
ability and subsequent use had not been widely investi-
gated. Equally under-investigated were contemporary
anti-malarial prescription and patient counselling prac-
tices. Even the quality of presumptive diagnostic prac-
tices, the primary basis for anti-malarial prescription
under the former protocol and a possible feature of the
new protocol for fever patients less than five years of
age, had not been previously examined. Accordingly, this
study aimed to document malaria case management
practices in PNG prior to the introduction of the new
malaria treatment protocol. It was anticipated that the
resulting findings would highlight potential barriers to
the successful implementation of the new protocol and
would serve as a baseline from which to measure the de-
gree of change in clinical practice that occurs following
its introduction. Specific research questions included:
What percentage of fever cases are tested for malaria in-
fection by microscopy or RDT? What percentage of
fever cases are prescribed an anti-malarial in accordance
with the current national malaria treatment protocol?
What percentage of test negative fever cases are pre-
scribed an anti-malarial? What percentage of fever cases
prescribed an anti-malarial are: advised on the purpose
of the medication, dosage/regimen instructions, dietary
considerations, or possible adverse effects; instructed to
return for further treatment if their symptoms persist or
deteriorate; given malaria prevention advice.
Methods
Study sites
PNG comprises 20 provinces split into four regions
known as Momose, Southern, Islands, and Highlands.
This national cross sectional survey was carried out in
areas with endemic or potentially epidemic malaria. The
Table 1 Sex and age of the clinical observation sample by
region (n= 468)
Characteristic Region Overall
Southern Highlands Momase Islands
Female n (%) 64 (51) 50 (46) 56 (46) 51 (47) 221 (47)
Age n (%) 0–4 yrs 60 (48) 48 (46) 58 (48) 49 (45) 215 (47)
5–15 yrs 31 (24) 14 (14) 30 (25) 35 (33) 110 (24)
16+ yrs 35 (28) 41 (40) 32 (27) 24 (22) 132 (29)
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sub-centres (collectively referred to as health centres in
this paper) and up to four aid posts selected from each
province using a simple random sampling procedure.
The sampling frame included all health centres oper-
ational in March 2010 inclusive of government and mis-
sion administered health facilities (N = 689). Aid posts
were randomly selected on site at participating (i.e. ran-
domly selected and consenting) health centres. The sam-
pling frame for aid posts was all operational aid posts
under the supervision of the health centre at the time of
survey. Hospitals were excluded from the sampling
frame as they are few in number and serve only a minor-
ity of the PNG population. Conversely, health centres
and aid posts are widely available across the country and
are the main providers of primary care.
Survey procedure
The study was carried out from June to November 2010
and was conducted by three trained field teams, each
comprising three members, working simultaneously at
different sites. The training programme for field staff
spanned 10 days and consisted of lectures on the project
background, malaria facts and effects, survey method-
ology, and intensive instruction and practice on the sur-
vey instruments. Members of each survey team spent
between three to five days at each participating health
centre and up to one day at each participating aid post.
Four survey instruments were completed at each health
facility, although this paper only reports data obtained
from the non-participant observation of malaria case
management (described below). The field team members
sought to observe the case management of all fever cases
presenting to each health facility for the duration of their
visit. Prior to any health facility visit, the respective pro-
vincial and district health authorities were informed of
the study objectives, sites, and timetable. The provincial
health authority was also asked to commission a health
officer to accompany the field team. Oral informed con-
sent was sought from the officer in charge at all partici-
pating health facilities and from all participating
clinicians and patients prior to clinical observation. The
study was approved and granted ethical clearance by the
Medical Research Advisory Committee of PNG (MRAC
No. 10.12; 26 Feb 2010).
Survey instrument
The survey instrument was designed to record observed
features of the clinical case management of patients pre-
senting with fever or a recent history of fever. The in-
strument was divided into discrete sections including
consultation and diagnosis, prescription and treatment
counselling. The content of each section was informed
with input from experienced medical- and medicalresearch- professionals. The instrument was completed
by a trained field team member who would silently ob-
serve the management of fever patients from the point
of initial contact with a health professional until service
exit or admission onto a treatment ward. During the
course of this observation, the field team member
recorded on the structured clinical observation instru-
ment whether specified actions did or did not occur and
recorded the content of specific actions (e.g. whether an
RDT was conducted and, if yes, what was the outcome?).
Eligible patients were identified upon first contact with a
health worker or, if circumstances allowed, by screening
in the waiting area prior to first contact with a health
worker.
Data analysis
All data were double entered into DMSys version 5.1
(Sigma Soft International). Intercooled Stata version 9
was used for descriptive data analysis and for calculating
95% confidence intervals (CIs). Odds ratios with their
corresponding 95% CI were calculated to assess the as-
sociation between selected patient, clinician and health
facility factors and receiving (or not) a diagnostic test for
malaria infection. The calculation of all CIs was adjusted
for possible clustering at the health facility level.
Results
Sample
A total of 605 clinical observations were completed with
patients presenting with fever or a recent history of fever
during the survey period. Patients who had been treated
for fever or malaria infection within 14 days prior to
interview were subsequently removed from analysis to
ensure the findings better represented initial malaria
case management practice. This restriction resulted in a
final sample of 468 clinical observations obtained from
54 health facilities. Table 1 presents sex and age charac-
teristics of the observed fever patients by region.
Diagnosis
Table 2 lists the percentage of fever patients observed
discussing a specified topic or receiving a specified pro-
cedure during the initial clinical consultation. As shown,
the topics most likely to be discussed during the clinical
Table 2 Percentage of fever/suspected malaria patients
observed discussing a specified topic or receiving a
specified procedure during initial clinical consultation
Topic of Discussion/Performed
Procedure
na Occurrence (%) 95% CI
DiscussionCurrent use of any medication 453 38.9 (30.9, 47.4)
Concurrent illness/existing
condition
452 74.3 (64.7, 82.1)
Pregnancy statusb 51 15.7 (6.5, 33.3)
Presence/recent experience
of fever
457 96.5 (91.8, 98.5)
Presence/recent experience
of cough
453 78.8 (73.2, 83.5)
Presence/recent experience
of head/body ache/pain
449 56.6 (48.8, 64.0)
Presence/recent experience
of nausea/vomiting
453 63.4 (55.4, 70.6)
Presence/recent experience
of diarrhoea
453 60.5 (53.2, 67.3)
Presence/recent experience
of chills
444 39.2 (30.8, 48.3)
Duration of current symptoms 455 90.5 (86.4, 93.5)
Procedure Health card examination 465 92.0 (87.5, 95.0)
Body temperature
measurement
463 86.8 (81.1, 90.4)
Body weight measurement 462 76.6 (68.4, 83.2)
Blood pressure measurement 455 4.6 (2.8, 7.5)
Abdomen palpation 461 16.9 (10.8, 25.6)
Eyes examination 460 16.3 (11.5, 22.6)
Palms examination 459 3.3 (1.5, 7.2)
Blood slide taken or
referral made
468 3.6 (1.2, 10.6)
RDT conducted or
referral made
468 15.0 (7.3, 28.2)
a. Each specified topic/procedure was scored ‘observed’, ‘not observed’ or
‘don’t know’. All ‘don’t know’ responses were excluded from the analyses,
hence the variation in reported numbers. b. Sample limited to females 15–40
years of age.
Table 3 Percentage of observed fever/suspected malaria
patients tested for malaria infection by blood slide, RDT
or either blood slide or RDT at health facilities in which
RDT and/or microscopy were available (n = 137)
Test Type(s) % Tested CI (95%)
Blood slide 10.9 (3.2, 31.6)
RDT 35.8 (17.1, 60.0)
Blood slide or RDT 40.9 (21.1, 64.1)
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fever (96.5% of cases), the duration of reported symp-
toms (90.5% of cases) and the presence or recent experi-
ence of cough (78.8% of cases). The topics least likely to
be discussed included pregnancy status (only 16% of
females aged between 15 and 40 years were questioned
about it), current use of any medication (38.9% of cases)
and the presence or recent experience of chills (39.2% of
cases). The three most frequently observed procedures
included the examination of a patient’s health card (92%
of cases), measuring body temperature (86.8% of cases)
and measuring body weight (76.6% of cases). The other
specified procedures were observed in fewer than 17% of
cases. In only 15% of cases was an RDT carried out and
in only 3.6% of cases was a blood smear taken. Theaverage number of specified topics discussed and speci-
fied procedures performed per observation was six out
of a possible total of nine (range 0–9; pregnancy status
was excluded from this calculation) and three out of a
possible total of eight (range 0–7; RDT and blood smear
were collapsed into a single ‘diagnostic test’ category for
this calculation), respectively.
Twelve (22%) of the 54 health facilities in which the
468 fever patients were collectively observed had unex-
pired RDT in stock or an operational microscope avail-
able at the time of the survey. Overall, 137 (29.3%) of
the 468 fever patients were observed at one of these 12
health facilities. Table 3 presents the percentage of these
137 patients tested for malaria infection by RDT, by
blood slide or by RDT or blood slide (as some overlap
was observed). The percentage of patients tested by
RDT or bloodslide in these health facilities varied by age
group; 30.4% (17/56) of patients aged less than five years
were tested for malaria infection compared to 50% (14/
28) of patients aged between five and fifteen years and
47.9% (23/48) of patients aged 16 years or older.
Factors potentially predictive of being tested for malaria
infection by RDT or microscopy were examined by logistic
regression among the 137 patients who presented to one
of the 12 health facilities with relevant diagnostic capacity.
The outcome variable was whether a patient had been
tested for malaria infection by RDT or microscopy (yes/
no). Predictor variables included patient age, patient sex,
location of health facility, clinician qualification, and clin-
ician experience. Results are presented in Table 4. As can
be seen, patients were more likely to be tested for malaria
infection by RDT or microscopy if they were five years or
older, treated by a health worker with more than 20 years
clinical experience or if they attended a health facility in
the Highlands region.
Prescription
Overall, 96.4% (451/468) of the observed fever patients
were provided with an anti-malarial prescription. The type
of anti-malarial(s) prescribed was recorded in 98% (440/
451) of cases. Of the 440 anti-malarial prescriptions
recorded, 79.8% (351/440) conformed to one or another of
the treatment recommendations current at the time of data
collection. This included prescriptions of amodiaquine plus
Table 4 Patient, clinician and health facility factors
associated with receiving a diagnostic test for malaria
infection in Papua New Guinea
Factors Diagnostic Status OR (95% CI) p
Test No test
Patient Age
Less than 5 years of age 17 39 1.00
5+ years of age 37 39 2.7 (1.1, 6.7) 0.032
Patient Sex
Female 29 37 1.00
Male 27 44 0.7 (0.3, 1.7) 0.440
Health Worker Qualification
Community Health Worker 21 35 1.00
HEO/nursing officer 32 42 1.4 (0.5, 3.5) 0.519
Clinical Experience
Less than 20 years experience 26 33 1.00
20+ years experience 26 17 2.5 (1.0, 6.3) 0.050
Health Facility Location
Highlands (less malarious) 27 20 1.00
Southern, Momase, Islands
(more malarious)
29 61 0.2 (0.1, 0.7) 0.006
Table 5 Patient, clinician and health facility factors
associated with receiving a recommended anti-malarial
prescription for malaria infection in Papua New Guinea
Factors Recommended
Prescription
OR (95% CI) p
Yes No
Patient age
Less than 5 years of age 158 46 1.00
5+ years of age 184 42 1.3 (0.7, 2.2) 0.397
Patient sex
Female 168 45 1.00
Male 182 45 1.1 (0.6, 1.9) 0.739
Health Worker Qualification
Community Health Worker 195 57 1.00
HEO/nursing officer 134 29 1.5 (0.8, 2.8) 0.192
Clinical Experience
Less than 20 years experience 144 24 1.00
20+ years experience 132 50 0.4 (0.2, 0.7) 0.002
Health Facility Location
Highlands (less malarious) 69 28 1.00
Southern, Momase, Islands
(more malarious)
282 62 2.6 (1.3, 5.1) 0.004
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SP (n=11), artemether or artesunate plus SP (n=7), and
chloroquine plus SP plus primaquine which is recom-
mended for the treatment of vivax malaria in adult patients
(n=18). Of the remaining prescriptions (89/440), 68 were
monotherapies (amodiaquine n= 27, chloroquine n=23,
artemether n=14, quinine n=3, SP n=1) or non-
recommended anti-malarial combinations (artemether +
primaquine n=8m SP+primaquine n= 3, amodiaquine+
primaquine n=3, amodiaquine+ chloroquine n=2, amo-
diaquine+ artemether n=1, chloroquine+primaquine
n=1, chloroquine+quinine n=1, chloroquine+SP+ arte-
mether n=1, and chloroquine+SP+doxycycline n=1).
Of the 351 patients provided a recommended anti-
malarial prescription, 39.3% (138/351) were required to
return to their respective health facility to complete the
prescription (i.e. ‘take away’ anti-malarial medication
was not provided), 57.3% 201/351 were provided a full
prescription to take home, and in 3.4% (12/351) of cases
the relevant information was not recorded. Of the 201
patients provided a recommended anti-malarial prescrip-
tion in take away form, the correct dosage for the re-
spective regimen was provided in 75.6% (152/201) of
cases, an incorrect dosage was provided in 15.9% (32/
201) of cases, and in 8.5% (17/201) of cases a determin-
ation as to the correctness (or otherwise) of the provided
medication dosage could not be made.
Factors potentially predictive of being prescribed a
recommended anti-malarial were examined by logisticregression among the 440 patients prescribed an anti-
malarial and for whom this prescription was recorded.
The outcome variable was whether a patient received a
recommended anti-malarial combination (yes/no), ex-
cluding dosage considerations. The predictor variables
were those previously described in Table 4. Results are
presented in Table 5. As can be seen, patients were more
likely to be prescribed a recommended anti-malarial if
they were treated by a health worker with less than 20
years’ clinical experience or if they attended a health fa-
cility in an area other than the Highlands region.
Of the 78 patients who were tested by RDT or blood
slide, the test result was recorded in 69 (86%) cases. Of
these 69 patients, 72% (50/69) tested negative for mal-
aria infection, 15% (17/69) positive and the test result
was invalid in 3% (2/69) of cases. An anti-malarial was
subsequently prescribed to 84% (58/69) of these patients,
including 82% (41/50) of patients who tested negative
for malaria infection and 100% (17/17) of test positive
cases. The blood slide or RDT result was available at the
time of anti-malarial prescription in 83% (57/69) of these
cases including 39 out of the 41 patients who tested
negative for malaria infection and were subsequently
prescribed anti-malarials.
Counselling
Table 6 displays the proportion of fever patients
observed to have been provided with each of six differ-
ent ‘types’ of clinical instruction by their respective
Table 6 Observed provision of instructions
Instruction na Provided (%) (95% CI)
Purpose of medication 435 63.4 (53.7, 72.0)
Dosage/regimen 441 75.7 (67.0, 82.5)
Dietary 449 6.2 (3.5, 10.8)
Possible adverse effects 449 1.1 (0.5, 2.6)
Health facility re-engagementb 447 27.7 (19.7, 37.4)
Prevention advice 448 10.3 (6.4, 16.1)
a. Each instruction was scored ‘provided’, ‘not provided’ or ‘don’t know’. All
‘don’t know’ responses were excluded from the analyses, hence the variation
in reported numbers.
b. In which patients are advised to return to the health facility if current
symptoms persist or deteriorate.
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had been prescribed anti-malarial medication. As shown,
the dosage instructions and the purpose of the medica-
tion supplied were explained in the majority of cases
(75.7% and 63.4%, respectively). Treatment re-
engagement instructions were the next most frequently
provided at 27.7%. Malaria prevention advice, dietary
instructions and the possible side effects of medication
supplied were provided in 10.3%, 6.2% and 1.1% of cases,
respectively. The duration of clinical consultation, from
first to last contact with a health worker/s (inclusive of
any waiting time between first and last contact), was
recorded in 93% (437/468) of cases. The mean consult-
ation time was 19.4 minutes (SD 15.9).
Discussion
Findings from this study indicate that microscopy or
RDT confirmed malaria diagnosis was the exception in
PNG under the former treatment protocol, collectively
occurring in less than 20% of observed malaria case
management consultations. Microscopy or RDT was
only available in 22% of the surveyed health facilities,
which clearly limited their use, although even in those
facilities with these diagnostic tools available only 40% of
fever patients were tested. Patients older than five years
of age were more likely to be tested for malaria infection
relative to younger patients, although still fewer than
50% of adult (16 years +) patients were tested in facilities
with the resources to do so. The study findings also sug-
gest that clinical diagnosis was often a far from exhaust-
ive process. Questions that could reasonably be expected
to be a mandatory component of a thorough clinical as-
sessment were often not asked and procedures such as
palpating the abdomen or examining the patients’ eyes
or palms were rarely conducted. Thus, it would appear
that most malaria diagnoses in PNG were made pre-
sumptively, simply on the basis of the presence of fever
without a thorough clinical examination and use of diag-
nostic tests. Anti-malarial provision to fever patients was
near universal with 96.4% of the observed fever casesreceiving a prescription, including the 41/50 patients
who tested negative for malaria infection by RDT or
blood slide.
These findings are of concern from a treatment per-
spective as evidence suggests many (and in some cases
most) fever patients in PNG, when tested by microscopy
or RDT, do not have malaria infection [19]. Numerous
patients, therefore, are likely to be receiving anti-
malarials unnecessarily and, as a result, may have experi-
enced a delay in appropriate diagnosis and treatment re-
sponse. The consequences of malaria misdiagnosis have
not been well examined in PNG, although international
evidence suggests it may contribute to ongoing ill health
and economic hardship, especially amongst the poorest
members of a community [20,21]. Malaria misdiagnosis
further contributes to the development of parasite resist-
ance to anti-malarial drugs, a significant problem in
PNG at present [22] and an issue of global concern with
respect to containing parasite resistance to the new
artemisinin-based anti-malarial drugs [23,24]. A malaria
misdiagnosis also incurs economic costs in the form of
unnecessary medication prescription, an issue of concern
in a developing country.
These findings highlight the substantial changes that
the revised PNG national malaria treatment protocol will
require in terms of malaria case management practice.
In particular, the proposed shift to routine testing of all
fever patients by RDT or microscopy and the prescrip-
tion of anti-malarials to test positive cases only are likely
to challenge currently entrenched practice. The em-
phasis on thorough patient counselling in the new treat-
ment protocol is also likely to take some adjusting to
given the practices observed in this study. For example,
the purpose of the prescribed medication was not
explained to patients in 36% of cases, dosage/regimen
instructions were not provided in 25% of cases, the pos-
sibility of adverse effects and what they might look like
were virtually never discussed, and instructions on when
to return to the health facility (if needed) were only pro-
vided in 28% of cases. On a more positive note, 79% of
prescriptions conformed to current treatment guidelines
and the prescription of mono-therapies was relatively
rare (68/440 prescriptions). These latter findings indicate
most clinicians are generally aware of and comply with
recommended prescription practices and may continue
to do so with the introduction of a revised protocol.
Conversely, these findings also indicate that outdated
mono-therapies were provided in over 15% of cases and
the treatment guidelines were not followed in 21% of
cases. Thus, full adherence to the new protocol in the
short- to mid-term is probably unrealistic if the same
has not been achieved with the former, familiar protocol.
Realistically, the successful transition from the former
to the revised national malaria treatment protocol, in
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extended period of time; all the more so given the de-
gree of change in clinical practice that will be required.
The experience from other developing countries that
have previously revised their national treatment proto-
cols in a manner consistent with that proposed in PNG
is instructive in this regard. In Kenya, in the first year
post-implementation of an ACT-based national malaria
treatment protocol, ACT was prescribed to fewer than
30% of fever patients [25]. Four years later the percent-
age of fever patients prescribed ACT in Kenya had risen
to over 60% [13]. Consistent with the Kenyan experi-
ence, a recent review of health worker prescribing prac-
tices identified that compliance with ACT prescribing
guidelines increases the longer guidelines have been in
place [26]. However, it was notable that even in health
facilities in which ACT was in stock, the prescription of
ACT to fever cases was below 70% in every study
included in the review and typically below 50% if the
study was conducted shortly after implementation of the
ACT-based guidelines. Findings pertaining to RDT use
depict a similar scenario. Health worker compliance with
the use of RDT kits to test for malaria infection has been
low [27], although not always [28], in the period imme-
diately following their introduction. A high level of
health worker compliance with RDT results also appears
difficult to achieve with many studies reporting anti-
malarial prescription to between 30 to 50+ % of test
negative cases [27-29], even when the testing
programme has been in place for some years [13].
What these studies collectively suggest is that achiev-
ing a high level of health worker compliance to a revised
RDT/ACT-based malaria treatment protocol takes a
number of years. A high proportion, possibly a third or
more, of test negative cases are still likely to be pre-
scribed anti-malarials some time after the introduction
of RDT kits and it is unlikely that more than 70–80% of
test positive cases will be prescribed the correct ACT
even two to three years post-implementation of a revised
protocol. Progress in PNG is unlikely to be any faster
given the level of change in malaria case management
practice that will be required. The potential barriers to
health worker compliance with malaria treatment proto-
cols are multiple, ranging from supply problems to peer/
patient pressures to insufficient and/or inappropriate
training/support to mistrust in the new medicines or
diagnostic resources [17,18,30,31]. A small number of
studies have sought to identify interventions that might
usefully improve adherence to malaria treatment guide-
lines, although often with limited success. For example,
the impact of a three-day, in-service training and the
provision of various resources and job aids on malaria
case management were modest at best in a pre-/post-
intervention study conducted in Kenya [32]. The authorssubsequently concluded that one-off training interven-
tions, even when supported by training materials and
job aids, are unlikely to be effective if follow-up support
and supervision is not provided. Reflecting the benefit of
regular longer-term support, a recent study demon-
strated a substantial improvement in health worker ad-
herence to malaria treatment guidelines via the
provision of regular text message reminders [33]. Ten
discrete text messages, each describing a recommended
malaria case management practice, were variously sent
to participating health workers personal mobile phones
twice a day, five days a week over a six-month period. A
24.5% improvement in malaria case management prac-
tice (based on adherence to national treatment guide-
lines) was subsequently observed in the intervention
group versus the control group six months post inter-
vention. Despite this promising result, there remain few
interventions that have been reliably demonstrated to
improve malaria case management practice [34] and al-
though regular supervision and follow-up support (via
any medium) may improve performance, complete or
even substantial adherence to a revised malaria treat-
ment protocol will still likely require an extended time
period.
The study presented in this paper was not without
limitations. The final sample size, and especially the
number of aid posts included in the sample, was lower
than anticipated. This was largely due to the inaccessibil-
ity of aid posts or, more frequently, the absence of any
functional aid post to survey. The study was conducted
during a period of low malaria transmission (June-No-
vember, 2010) in those provinces with seasonal variation.
Thus, the number of malaria patients presenting to
health facilities and the subsequent pressure on staff and
resources (e.g. RDT kits, anti-malarial medication) may
have been lower during the survey period as opposed to
peak transmission periods. Clinical observations may
also have been subject to some form of bias given that
participating clinicians were aware that they were being
observed and their practice assessed. Any such bias was
likely to have been in the direction of promoting a more
thorough or accurate (according to current guidelines)
clinical case consultation, although possible anxieties
associated with the knowledge that one was being
assessed may have negatively impacted on clinical per-
formance in some cases. In health centre settings this
source of potential bias was hopefully minimized given
the duration of the observations (five days), although it
cannot be discounted completely. The reported percent-
age of ‘correct’ anti-malarial prescriptions may be an
overestimate as information on the severity of illness
(uncomplicated vs. severe malaria) was not available.
However, 96.1% (423/44) of patients included in this
analysis were sent home at the conclusion of their
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was the most likely diagnosis. Similarly, the assessment
of whether an anti-malarial prescription was provided in
the correct dosage (or not) was based on patient age as
opposed to weight. Finally, the sample size employed in
the regression analysis presented in Table 4 was low and
the reported findings should be considered highly
tentative.
Conclusion
The findings presented in this paper strongly indicate that
the new PNG national malaria treatment protocol will re-
quire a substantial change in clinical practice if it is to be
correctly implemented and adhered to. Areas that will re-
quire the most change include the shift from presumptive
to RDT/microscopy confirmed diagnosis, prescribing (or
rather non-prescribing) of anti-malarials to patients who
test negative for malaria infection, and the provision of
thorough treatment counselling. The successful introduc-
tion and maintenance of the proposed changes to clinical
practice, therefore, will likely necessitate a comprehensive
clinician support programme, possibly inclusive of
‘booster’ training opportunities and regular clinical super-
vision. The introduction of a revised malaria treatment
protocol also presents as an excellent opportunity to iden-
tify effective health worker support mechanisms via sound
research methodology.
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